Form D · Biotechnology
Solarea Bio, Inc.
Waltham, MA · CIK 0001823902
Offering snapshot reported Nov 20, 2025 · SEC filing
- Reported sold
- $9.91M Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2025 | Initial | $9,910,397 | No comparison | 5 | SEC filing |
| Sep 10, 2024 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| May 9, 2023 | Initial | $14,999,999 | No comparison | 4 | SEC filing |
| Sep 11, 2020 | Initial | $11,326,613 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564502
Source: Form D, filed Nov 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Catherine Balsam Schwaber | Director, Executive |
| Neal Bhadkamkar | Director |
| Anula Jayasuriya | Director |
| Ilissa Larimore | Executive |
| Eric Schott | Executive |
| Gregory Sieczkiewicz | Director |
| Gerardo Toledo | Director, Executive |
| Matthew Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Beaver Street Suite 308
Waltham, MA, 02453
Waltham, MA, 02453